- Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify
Malgorzata A. Komor et al, 2017, Molecular & Cellular Proteomics CrossRef - Targeted splicing therapy: new strategies for colorectal cancer
Yifeng Zheng et al, 2023, Frontiers in Oncology CrossRef - The effect of spleen tyrosine kinase inhibitor R406 on diabetic retinopathy in experimental diabetic rats
Xian Su et al, 2020, International Ophthalmology CrossRef - Targeting the splicing isoforms of spleen tyrosine kinase affects the viability of colorectal cancer cells
Vincent Denis et al, 2022, PLOS ONE CrossRef - Alternative RNA Splicing—The Trojan Horse of Cancer Cells in Chemotherapy
Nikolay Mehterov et al, 2021, Genes CrossRef - Phosphorylation of (Ser 291) in the linker insert of Syk negatively regulates ITAM signaling in platelets
Carol Dangelmaier et al, 2024, Platelets CrossRef - Genome-Wide Profiling of Prognostic Alternative Splicing Signature in Colorectal Cancer
Zhen Zong et al, 2018, Frontiers in Oncology CrossRef - Melittin inhibited glycolysis and induced cell apoptosis in cisplatinresistant lung adenocarcinoma cells via TRIM8
SUFANG ZHANG et al, 2021, BIOCELL CrossRef - Biochemical characterization of spleen tyrosine kinase (SYK) isoforms in platelets
Pankaj Kumar Singh et al, 2023, Platelets CrossRef - Mapping alternative splicing events in colorectal cancer
Yifeng Zheng et al, 2024, Discover Oncology CrossRef - Knockdown of TRIM65 inhibits autophagy and cisplatin resistance in A549/DDP cells by regulating miR-138-5p/ATG7
Xufeng Pan et al, 2019, Cell Death & Disease CrossRef - High mRNA expression of splice variant SYK short correlates with hepatic disease progression in chemonaive lymph node negative colon cancer patients
Robert R. J. Coebergh van den Braak et al, 2017, PLOS ONE CrossRef - Spleen tyrosine kinase facilitates the progression of papillary thyroid cancer regulated by the hsa_circ_0006417/miR‐377‐3p axis
Guangmou Tan et al, 2024, Environmental Toxicology CrossRef - MicroRNA and Alternative mRNA Splicing Events in Cancer Drug Response/Resistance: Potent Therapeutic Targets
Rahaba Marima et al, 2021, Biomedicines CrossRef